CSF-1 as a Prognostic Indicator in Ovarian Cancer
Author Information
Author(s): S.M. Scholl, C.H. Bascoul, V. Mosseri, R. Olivares, H. Magdelenat, T. Dorval, T. Palangie, P. Validire, P. Pouillart, E.R. Stanley
Primary Institution: Institut Curie
Hypothesis
Is circulating colony-stimulating factor 1 (CSF-1) a reliable prognostic indicator for patients with epithelial ovarian cancer?
Conclusion
Elevated levels of CSF-1 are significantly associated with worse survival outcomes in patients with epithelial ovarian cancer.
Supporting Evidence
- An elevated CSF-1 concentration was significantly associated with worse survival.
- Mean CSF-1 levels dropped significantly during chemotherapy.
- CA125 levels did not correlate with prognosis in patients at the start of chemotherapy.
Takeaway
This study found that higher levels of a substance called CSF-1 in the blood can mean that ovarian cancer is more serious and that patients might not live as long.
Methodology
Serum samples from 82 patients were analyzed for CSF-1 and CA125 levels, and their survival outcomes were tracked.
Potential Biases
Potential bias due to the retrospective nature of the study and the specific patient population.
Limitations
The study's findings may not apply to all types of ovarian cancer, and the sample size is relatively small.
Participant Demographics
Mean age of participants was 52, with all tumors being of epithelial origin.
Statistical Information
P-Value
0.02
Statistical Significance
p=0.02
Want to read the original?
Access the complete publication on the publisher's website